Interventional Clinical Trial for CCSVI in Multiple Sclerosis Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

August 1, 2017

Study Completion Date

August 1, 2017

Conditions
Multiple Sclerosis
Interventions
PROCEDURE

Catheter venography with balloon venoplasty

All eligible patients will undergo catheter venography with balloon venoplasty and/or sham at baseline and at week 48 (i.e. Cross over design) followed by clinical and radiologic observation for a minimum of 48 weeks after each procedure.

DEVICE

Catheter venography with balloon venoplasty and balloon

Trial Locations (4)

V6T 2B5

Vancouver Coastal Health - University of British Columbia Hospital, Vancouver

R3A 1R9

University of Manitoba Health Sciences Centre, Winnipeg

H2L 4M1

Centre Hospitalier de l'Université de Montréal, Montreal

G1J 1Z4

CHU de Québec - Hôpital de l'Enfant-Jésus, Québec

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Multiple Sclerosis Society of Canada

OTHER

lead

University of British Columbia

OTHER

NCT01864941 - Interventional Clinical Trial for CCSVI in Multiple Sclerosis Patients | Biotech Hunter | Biotech Hunter